SECORA MICHAEL (CFO & Chief Corp Dev Ofcr) reported 1 transaction at IAMBIC THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/19/2026ACC: 0001855980-26-000009
Officer· CFO & Chief Corp Dev Ofcr
Since Oct 2026
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
61.34K acquired · 61.34K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+61.34K
Price / share
—
Trade value
—
% of position
28.1%
10/16/2026
218.56K→279.90K
Total
Net shares
+61.34K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/16/2026 | C · Conversion | +61.34K | — | — | 28.1% | 218.56K | 279.90K |
| Total | +61.34K | $0.00 | ||||||
Derivative Transactions1
Series B-3 Convertible Preferred Stock
Direct
Converts to
Common Stock
61.34K shares
Shares
−61.34K
Strike price
Held after
0.00
Exercisable
—
10/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B-3 Convertible Preferred Stock Direct | Common Stock61.34K shares | 10/16/2026 | C · Conversion | −61.34K | — | 0.00 |